Legacy Bridge’s Idexx Laboratories IDXX Stock Holding History

Legacy Bridge’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13	Closed	-$8.79K	–	398
2025 Q4	$8.79K	Buy	+13	New	+$8.85K	﹤0.01%	318

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Legacy Bridge's IDXX Position: Q1 2026 in Review

Legacy Bridge sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 13 shares — an estimated $8.79K sold.

Legacy Bridge first reported a position in IDXX in Q4 2025 and held it in 1 quarter. The position peaked at $8.79K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Legacy Bridge reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
Legacy Bridge sold 13 Idexx Laboratories shares in Q1 2026, an estimated $8.79K.
Legacy Bridge first reported a position in Idexx Laboratories in Q4 2025 and held it in 1 quarter.
Legacy Bridge's Idexx Laboratories position peaked at $8.79K in Q4 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Legacy Bridge's 13F filing for Q1 2026, filed 14 May 2026.